New bowel tumor drug helped cure cancer in 100% of cases

GSK announced a major breakthrough concerning cancer therapy. A drug called Jemperli (dostarlimab) showed impressive results in a phase 2 trial at the Memorial Sloan Kettering Cancer Center (MSK). The study included 42 patients suffering from mismatch repair deficient (dMMR) locally advanced rectal cancer, a type of bowel cancer.

Used as a first-line treatment and an alternative to chemotherapy and surgery, Jemperli cured cancer in all patients, showing "an unprecedented 100% clinical complete response rate." Tests that followed showed no evidence of remaining tumors. Moreover, the first 24 of the 42 patients were observed after an average time of 26.3 months, and they showed no signs of cancer resurfacing.

GSK will test the drug in additional studies involving certain types of colorectal cancers.

Continue reading...

The post New bowel tumor drug helped cure cancer in 100% of cases appeared first on BGR.

Today's Top Deals

1. Today’s deals: Memorial Day sales on Dyson vacuums, WiFi 6 routers, NERF guns, Ray-Ban sunglasses, more
2. Today’s deals: $189 Apple Watch SE, $299 3D printer, $829 M2 MacBook Air, $300 GoPro HERO12 Black, more
3. Best Apple Watch deals for June 2024
4. Today’s deals: $199 Bose soundbar, $38 Sony headphones, Energizer batteries, $200 off DJI Explorer, more

New bowel tumor drug helped cure cancer in 100% of cases originally appeared on BGR.com on Tue, 4 Jun 2024 at 13:56:00 EDT. Please see our terms for use of feeds.